338 related articles for article (PubMed ID: 28866224)
1. Highlights in nanocarriers for the treatment against cervical cancer.
Medina-Alarcón KP; Voltan AR; Fonseca-Santos B; Moro IJ; de Oliveira Souza F; Chorilli M; Soares CP; Dos Santos AG; Mendes-Giannini MJS; Fusco-Almeida AM
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():748-759. PubMed ID: 28866224
[TBL] [Abstract][Full Text] [Related]
2. Update on the Use of Nanocarriers and Drug Delivery Systems and Future Directions in Cervical Cancer.
Himiniuc LM; Toma BF; Popovici R; Grigore AM; Hamod A; Volovat C; Volovat S; Nica I; Vasincu D; Agop M; Tirnovanu M; Ochiuz L; Negura A; Grigore M
J Immunol Res; 2022; 2022():1636908. PubMed ID: 35571568
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers for the Effective Treatment of Cervical Cancer: Research Advancements and Patent Analysis.
Pathak K; Akhtar N
Recent Pat Drug Deliv Formul; 2018; 12(2):93-109. PubMed ID: 29611489
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
6. Colloidal Nanocarriers as Versatile Targeted Delivery Systems for Cervical Cancer.
Sugumaran A; Mathialagan V
Curr Pharm Des; 2020; 26(40):5174-5187. PubMed ID: 32586249
[TBL] [Abstract][Full Text] [Related]
7. A Recent Advancement in Nanotechnology Approaches for the Treatment of Cervical Cancer.
Hegde YM; Theivendren P; Srinivas G; Palanivel M; Shanmugam N; Kunjiappan S; Vellaichamy S; Gopal M; Dharmalingam SR
Anticancer Agents Med Chem; 2023; 23(1):37-59. PubMed ID: 35570521
[TBL] [Abstract][Full Text] [Related]
8. Development of Drug Targeting and Delivery in Cervical Cancer.
Aggarwal U; Goyal AK; Rath G
Curr Cancer Drug Targets; 2018; 18(8):792-806. PubMed ID: 29032751
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
[TBL] [Abstract][Full Text] [Related]
10. Cancer chemotherapy with lipid-based nanocarriers.
Liu D; Zhang N
Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
12. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.
Din FU; Aman W; Ullah I; Qureshi OS; Mustapha O; Shafique S; Zeb A
Int J Nanomedicine; 2017; 12():7291-7309. PubMed ID: 29042776
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Management by Herbal Drug-Based Nanocarriers: An Overview.
Kulwal V; Baxi K; Sawarkar SP; Bhatt LK
Crit Rev Ther Drug Carrier Syst; 2020; 37(1):65-104. PubMed ID: 32450014
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
15. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
16. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
[TBL] [Abstract][Full Text] [Related]
17. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
Luo MX; Hua S; Shang QY
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
[TBL] [Abstract][Full Text] [Related]
18. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
Danhier F; Feron O; Préat V
J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
[TBL] [Abstract][Full Text] [Related]
19. Drug nanocarriers and functional nanoparticles: applications in cancer therapy.
Thierry B
Curr Drug Deliv; 2009 Aug; 6(4):391-403. PubMed ID: 19534706
[TBL] [Abstract][Full Text] [Related]
20. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
Ho BN; Pfeffer CM; Singh ATK
Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
